2
1

Company News

Industry News

The company fluoxetine for the treatment of pigment decolorization disease application project were authorized

Published on:

2018-04-02

The company fluoxetine for the treatment of pigment decolorization disease application project were authorized

Latest News

Ceftriaxone sodium, the major product of the company, was certified by Brazil ANVISA

2020-08-12

Ceftriaxone sodium, the major product of the company, was certified by Brazil ANVISA

2019-05-29

The company fluoxetine for the treatment of pigment decolorization disease application project were authorized

2018-04-02

Shandong Ruiying Runze Pharmaceutical Group participated in the 78th National Pharmaceutical Trade Fair, and launched a grand la

2018-02-24

The wind and rain together to write the Spring and Autumn, to join hands and create brilliant! - Warmly celebrate the 27th anniv

2018-01-18

The company participated in the 78th China pharmaceutical fair

2017-11-28